| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/10/1996 | CN1120337A Process for production of an imidazole derivative |
| 04/10/1996 | CN1120313A Heart failure remedy |
| 04/10/1996 | CN1120042A Substituted 1-(7-chloroquinolin-4-yl)pyrazole-3-carboxamide N-oxide derivatives, method of preparing them and the pharmaceutical compositions in which they are present |
| 04/10/1996 | CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same |
| 04/10/1996 | CN1119952A External applying medicine powder for treating essential hypertension |
| 04/09/1996 | US5506347 Lyxofuranosyl analogues of adenosine |
| 04/09/1996 | US5506266 Controls free radical induced damage arising from myocardial infraction or stroke, perticularyl heart damage |
| 04/09/1996 | US5506258 Exhibit affinity for the biological receptors of neuropeptides y, which are present in the central and peripheral nervous systems |
| 04/09/1996 | US5506243 Sulfonamide derivatives |
| 04/09/1996 | US5506240 Hypotensive agents |
| 04/09/1996 | US5506237 Bicyclic nitrogen compounds |
| 04/09/1996 | US5506230 Oil in water emulsion consists of 2,3-dihydro-1h indene cmpound, an oil, phospholipid as an emulsifier, glycerol as an isotonic agent and water; useful for improving anoxemic and hypoxic syndromes, prevents arrythemia and heart failure |
| 04/09/1996 | US5506229 Skeletal and muscle disorders |
| 04/09/1996 | US5506220 Derivatives of 17-alpha-hydroxy-3,20-dioxo-19-norpregna-4-ene |
| 04/09/1996 | US5506204 Muramyl compounds for treatment of septic shock |
| 04/09/1996 | US5506133 Polypeptide |
| 04/09/1996 | CA1338238C Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| 04/04/1996 | WO1996010035A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009828A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/04/1996 | WO1996009827A2 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 04/04/1996 | WO1996009826A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | WO1996004323A3 Gas phase production of polydienes |
| 04/04/1996 | WO1996000288A3 Class bi and ci scavenger receptors |
| 04/04/1996 | CA2200858A1 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | CA2200436A1 Combination therapy for hypercholesterolemia |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704434A1 6-Amino-1,4-dihydropyridines and their use as selective k-channel modulators |
| 04/03/1996 | EP0704431A2 Ortho-substituted benzoic acid derivatives |
| 04/03/1996 | EP0704217A2 Method for vascular embolization and vascular embolizing agent |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0704057A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 04/03/1996 | EP0704056A1 Leukocyte adhesion assay |
| 04/03/1996 | EP0703914A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist |
| 04/03/1996 | EP0703910A1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
| 04/03/1996 | EP0703904A1 Pyrimidine cyanoguanidines as k-channel blockers |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0703780A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 04/03/1996 | EP0490891B1 Drug containing matrix |
| 04/03/1996 | EP0458861B1 Composition for reparation and prevention of fibrotic lesions |
| 04/03/1996 | CN1119861A 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 04/03/1996 | CN1119858A New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 04/03/1996 | CN1119830A Antisense inhibition of C-MYC to modulate the proliferation of smooth muscle cells |
| 04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
| 04/02/1996 | US5504216 Method for reparing an amorphous sulfonamide |
| 04/02/1996 | US5504207 Reacting 4-amino-2-chloro-6,7-dimethoxyquinazoline with n-(2-tetrahydrofuroyl)piperazine in anhydrous polar solvent without acid scavenger |
| 04/02/1996 | US5504108 Optically pure 4-aryl-2-hydroxytetronic acids |
| 04/02/1996 | US5504107 Anticoagulants, preventing atherosclerosis |
| 04/02/1996 | US5504088 Acetylcholine esterase inhibitors; alzheimer's disease and other diseases caused by a low concentration of choline |
| 04/02/1996 | US5504080 Benzo-fused lactams |
| 04/02/1996 | US5503831 Foodstuff; obesity treatment |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
| 03/28/1996 | WO1996009392A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) [Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) [APO(a)] |
| 03/28/1996 | WO1996009318A1 Method and pharmaceutical composition for prevention and treatment of brain damage |
| 03/28/1996 | WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin |
| 03/28/1996 | WO1996009302A1 Bicyclic carboxamides as 5-ht1a antagonists |
| 03/28/1996 | WO1996009294A1 Substituted heteroaromatic compounds and their use in medicine |
| 03/28/1996 | WO1996009287A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 03/28/1996 | WO1996009065A1 Method of treating hypertension in pregnant mammals |
| 03/28/1996 | WO1996009064A1 Method and pharmaceutical composition for prevention and treatment of brain damage |
| 03/28/1996 | WO1996009058A1 Remedy and preventive for nervous system disorder |
| 03/28/1996 | WO1996009041A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | CA2202526A1 Therapeutic and prophylactic agent for nervous disturbances |
| 03/28/1996 | CA2200472A1 Novel heterocyclic derivatives, method of prodution thereof and pharmaceutical use thereof |
| 03/28/1996 | CA2200443A1 Bicyclic carboxamides as 5-ht1a antagonists |
| 03/28/1996 | CA2200204A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | CA2199727A1 Ribozyme treatment of diseases or conditions related to levels of plasma lipoprotein (a) ¬lp(a)| by inhibiting apolipoprotein (a) ¬apo(a)| |
| 03/28/1996 | CA2199022A1 Method of treating hypertension in pregnant mammals |
| 03/27/1996 | EP0703231A1 2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome |
| 03/27/1996 | EP0703229A2 Process for the preparation of (R)-3-amino-5-methoxychroman |
| 03/27/1996 | EP0702681A1 Spiro-substituted azacycles as neurokinin antagonists |
| 03/27/1996 | EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/27/1996 | EP0702557A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 03/27/1996 | EP0702518A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 03/27/1996 | EP0651747B1 Carbostyryl derivatives |
| 03/27/1996 | EP0646005A4 Methods for treating arteriosclerosis. |
| 03/27/1996 | EP0262125B1 AICA riboside for the prophylactic treatment of diseases with restricted blood flow. |
| 03/27/1996 | CN1119440A 2,6-diaminopurine derivatives |
| 03/27/1996 | CN1119434A Phenoxyphenylacetic acid derivatives |
| 03/27/1996 | CN1119189A New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them |
| 03/27/1996 | CN1119187A oxalylamino-benzofuran- and benzothienyl-derivatives |
| 03/27/1996 | CN1119183A Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 03/27/1996 | CN1119111A Garlic extract capsule and garlic powder capsule, and producing process thereof |
| 03/27/1996 | CN1119099A Method for preparing pharmacologically active CNS composition |
| 03/27/1996 | CN1031404C Process for production of substituted azole |
| 03/27/1996 | CA2159034A1 Method of minimizing hepatic reperfusion injury |
| 03/26/1996 | US5502237 1-aryloxy-3-alkylamino-2-propanol-nitrate esters, the use thereof and corresponding pharmaceutical composition |
| 03/26/1996 | US5502216 Anticholesterol |
| 03/26/1996 | US5502198 α-aryl or heteroaryl-substituted amide ester ACAT inhibitors |
| 03/26/1996 | US5502094 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use |
| 03/26/1996 | US5502077 Fatty acid composition |
| 03/26/1996 | US5502066 Inhibitors of tumor necrosis factors |
| 03/26/1996 | US5502062 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use |
| 03/26/1996 | US5502050 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 03/26/1996 | US5502049 Use of phenothiazine derivatives in the treatment of ischaemia and/or hypoxia |
| 03/21/1996 | WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |